🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Optic Glioma

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery NCT03510208Phase 1, Phase 21 site📍 Palo Alto Stanford University · Tests: Near-Infrared Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800, POINPOINT-IR9000 Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab-IRDye800 Loupe-Based Intraoperative Fluorescence Imaging NCT04780009n/a1 site📍 Lexington Guoqiang Yu Modified CV Regimen in Optic Pathway Glioma NCT05278715Phase 21 site📍 Beijing Beijing Sanbo Brain Hospital · Tests: Carboplatin, Vincristine, Recombinant human endostatin Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462n/a3 sites📍 Maastricht📍 Groningen📍 Delft Maastricht Radiation Oncology · Tests: ProTRAIT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy